C
Market Data
$15.67+$4.51 (+40.41%)
CRVS · Last trade
Prev Close
$11.16
Range (29d)
$11.60 – $16.20
Recent Filings
- 8-K194.9 KBCorvus Pharmaceuticals, Inc.Jun 12, 4:01 PM ET·0001171843-26-004094
- 8-K2.4 MBCorvus Pharmaceuticals, Inc.May 14, 7:01 AM ET·0001171843-26-003397
- 10-Q8.1 MBCorvus Pharmaceuticals, Inc.May 7, 4:05 PM ET·0001104659-26-057100
- 8-K275.4 KBCorvus Pharmaceuticals, Inc.May 7, 4:01 PM ET·0001171843-26-003154
- 8-K144.6 KBCorvus Pharmaceuticals, Inc.Apr 23, 4:30 PM ET·0001104659-26-047735
- 8-K495.4 KBCorvus Pharmaceuticals, Inc.Mar 13, 8:46 AM ET·0001104659-26-027390
- 10-K12.4 MBCorvus Pharmaceuticals, Inc.Mar 12, 4:05 PM ET·0001104659-26-027047
- 8-K286.2 KBCorvus Pharmaceuticals, Inc.Mar 12, 4:02 PM ET·0001171843-26-001526
- 8-K550.3 KBCorvus Pharmaceuticals, Inc.Jan 23, 6:06 AM ET·0001104659-26-005968
- 8-K192.8 KBCorvus Pharmaceuticals, Inc.Jan 20, 4:12 PM ET·0001104659-26-005035
Insiders
10- ADAMS STREET PARTNERS LLC10% Owner
- Arcara JeffreyChief Business Officer
- Buggy Joseph JEVP Discovery Research
- CLARK IAN TDirector
- Chan Andrew C.Director
- Coloma Jason VSVP, Chief Business Officer
- EcoR1 Capital, LLC10% Owner
- Gould Terry PDirector, 10% Owner
- Grais LindaDirector
- Hunt Daniel W.SVP, Chief Business Officer
Tickers
Addresses
business
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO, CA, 94080
mailing
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO, CA, 94080